Recent Thoughts
- SGLT2 Inhibitors at Low GFR: Are We Drawing the Line in the Wrong Place?
- PharmaCare in BC: Bridging the Gaps in Prescription Coverage
- Reducing Prescription Drug Costs in Canada
- Tips for Starting an SGLT2 Inhibitor
- Ten Ways Health IT Could Improve Access to Physicians
- Finerenone After RAAS and SGLT2 Inhibition: Is Triple Therapy Appropriate?
- Most Impactful Clinical Trials for Slowing CKD Progression
- How EMPA-KIDNEY Changed Clinical Care in CKD
- Personalized Decision Support: From NNT to iNNT
- Could SPRINT Change the Systolic Blood Pressure Target?
Recent Comments